Close

AMRN and CSLLY Related Headlines

Go Back

Feb 28, 2023 08:00AM Amarin and CSL Seqirus Announce Exclusive License and Distribution Agreement to Commercialize VAZKEPA® (Icosapent Ethyl) in Australia and New Zealand

AMRN and CSLLY Related Press Releases

Go Back

Feb 28, 2023 08:00AM Amarin and CSL Seqirus Announce Exclusive License and Distribution Agreement to Commercialize VAZKEPA® (Icosapent Ethyl) in Australia and New Zealand

AMRN and CSLLY Related SEC Filings

Go Back